Literature DB >> 478188

A multicenter inquiry into the etiology of pancreatic diseases.

H Sarles, R C Cros, J M Bidart.   

Abstract

A multicenter study on the etiology and diet of patients with pancreatic diseases has been realized with the collaboration of 36 centers in 19 countries having widely different climatic and racial conditions. 2,478 cases were studied: acute pancreatitis (AP), 222 males, 208 females; calcified chronic pancreatitis (CCP), 801 males, 134 females; non-calcified chronic pancreatitis (NCCP), 525 males, 155 females; pancreatic cancer (PK), 69 males, 14 females; controls, 281 males, 62 females. The analysis of mutual information and the factorial analysis of correspondences have been used. With regard to chronic pancreatitis, the 19 countries could be classified into 4 classes presenting relative similarities. (A) Southern Europe: The diet is rich in carbohydrates, protein and lipids, alcohol intake is primarily in the form of wine and the pathology is dominated by CCP. There are much fewer women than men with chronic pancreatitis. (B) Northern Europe, to which may be added Argentina and Chile, is characterized by a protein- and lipid-rich diet, a beer-based alcohol consumption and a distinct prevalence of AP and NCCP. The prevalence of males with chronic pancreatitis is less marked than in southern Europe. (C) Japan has a lipid-poor diet and a low frequency of CCP and NCCP. (D) A fourth group is mostly composed of tropical countries with mixed races. It may be divided into 2 subclasses: (a) India is the most characteristic country of the first type with low fat, low protein diet, no alcoholism, high frequency of CCP (at an early age); (b) Brasil and South Africa are representative of the second subclass with very high alcohol intake in the form of spirits and a high frequency of CCP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478188     DOI: 10.1159/000198331

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  15 in total

1.  What determines susceptibility to liver damage from alcohol?: discussion paper.

Authors:  J B Saunders; A D Wodak; R Williams
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

2.  Exocrine pancreatic function of children from the Ivory Coast compared to French children. Effect of kwashiorkor.

Authors:  J F Sauniere; H Sarles; Y Attia; A Lombardo; T N Yoman; R Laugier; K Manlan; J Sahel
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

3.  Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors:  J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

4.  Pancreatitis in Finland between 1970 and 1989.

Authors:  M Jaakkola; I Nordback
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

5.  Etiology of chronic calcifying pancreatitis in Brazil: a report of 329 consecutive cases.

Authors:  R Dani; F J Penna; C E Nogueira
Journal:  Int J Pancreatol       Date:  1986-12

6.  Endoscopic management of chronic pancreatitis.

Authors:  Veeral M Oza; Michel Kahaleh
Journal:  World J Gastrointest Endosc       Date:  2013-01-16

7.  Is tobacco a risk factor for chronic pancreatitis and alcoholic cirrhosis?

Authors:  M Bourliere; M Barthet; P Berthezene; J P Durbec; H Sarles
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Etiology of chronic pancreatitis: has it changed in the last decade?

Authors:  Raffaele Pezzilli
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

9.  Surgery for chronic pancreatitis in Zaria, Nigeria.

Authors:  O A Mabogunje; J H Lawrie
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

Review 10.  Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain.

Authors:  Raffaele Pezzilli; Antonio M Morselli-Labate
Journal:  Int J Environ Res Public Health       Date:  2009-11-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.